Literature DB >> 22239592

Economic impact of early detection and early intervention of psychosis.

Lucia R Valmaggia1, Philip K McGuire, Paolo Fusar-Poli, Oliver Howes, Paul McCrone.   

Abstract

BACKGROUND: Whilst there is a growing body of evidence relating to the effectiveness of early detection and early intervention services there have been relatively few studies which have provided information on whether they are cost-effective. AIM: The aim of this paper is to review the cost-effectiveness evidence for early detection and early intervention in psychosis.
METHODS: Full economic evaluations, cost studies, and studies which do not report costs but do provide important resource use information were included in the review.
RESULTS: All cost effectiveness analysis to date suggest that it is possible to offer help early in the development of psychosis in a cost effective manner.
CONCLUSIONS: The potential longer term economic benefits of early detection and early intervention are required.

Entities:  

Mesh:

Year:  2012        PMID: 22239592     DOI: 10.2174/138161212799316145

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  7 in total

1.  Measuring The Lifetime Costs Of Serious Mental Illness And The Mitigating Effects Of Educational Attainment.

Authors:  Seth A Seabury; Sarah Axeen; Gwyn Pauley; Bryan Tysinger; Danielle Schlosser; John B Hernandez; Hanke Heun-Johnson; Henu Zhao; Dana P Goldman
Journal:  Health Aff (Millwood)       Date:  2019-04       Impact factor: 6.301

2.  The efficacy of CBT for severe mental illness and the challenge of dissemination in routine care.

Authors:  Mark van der Gaag
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

3.  Four-Year Cost-effectiveness of Cognitive Behavior Therapy for Preventing First-episode Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.

Authors:  Helga K Ising; Joran Lokkerbol; Judith Rietdijk; Sara Dragt; Rianne M C Klaassen; Tamar Kraan; Nynke Boonstra; Dorien H Nieman; David P G van den Berg; Don H Linszen; Lex Wunderink; Wim Veling; Filip Smit; Mark van der Gaag
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

4.  Prenatal genetic counselling for psychiatric disorders.

Authors:  Angela Inglis; Emily Morris; Jehannine Austin
Journal:  Prenat Diagn       Date:  2016-08-23       Impact factor: 3.050

5.  Development of a Boston Treatment Program for Youth at Clinical High Risk for Psychosis: Center for Early Detection, Assessment, and Response to Risk (CEDAR).

Authors:  Michelle S Friedman-Yakoobian; Michelle L West; Kristen A Woodberry; Keira E O'Donovan; Suzannah V Zimmet; Andréa Gnong-Granato; Anthony J Giuliano; Margaret E Guyer; Janine Rodenhiser-Hill; Matcheri S Keshavan; Larry J Seidman
Journal:  Harv Rev Psychiatry       Date:  2018 Sep/Oct       Impact factor: 3.732

6.  Patients With First-Episode Psychosis are Not a Homogeneous Population: Implications for Treatment.

Authors:  Angelo Cocchi; Giorgio Cerati; Antonio Lora; Anna Meneghelli; Emiliano Monzani; Mauro Percudani; Lorenzo Petrovich; Fiorino Mirabella; Angelo Picardi; Antonio Preti
Journal:  Clin Pract Epidemiol Ment Health       Date:  2014-02-07

7.  Discussing the psychiatric manifestations of 22q11.2 deletion syndrome: an exploration of clinical practice among medical geneticists.

Authors:  Emily Morris; Angela Inglis; Jan Friedman; Jehannine Austin
Journal:  Genet Med       Date:  2013-04-11       Impact factor: 8.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.